Rectal epithelial proliferation in persons post sporadic colorectal neoplasia.
Some studies have shown diffuse large bowel epithelial hyperproliferation in persons having colorectal neoplasia. Thus, measurements of rectal epithelial proliferation (REP) could be useful as a screening biomarker of risk for sporadic neoplasia. We examined REP, by autoradiography with tritiated thymidine, in 84 persons: 32 healthy volunteers, 37 who had had sporadic adenomas and 15 post cured sporadic colorectal cancer. Measurements of the labelling index (ratio of labelled to total number of crypt cells) showed a statistically insignificant but increasing gradient of hyperproliferation related to degree and invasiveness of neoplasia. However, this became significant when examining the proportion of labelled crypt compartments in each group and by comparing combined compartments 3 and 4 of cancer patients to non-cancer patients. Gender and age were found to be parameters that influenced the results. Using standard methods of analysis of REP, the lack of clear separation between risk groups limits the usefulness of REP measurements as a screening biomarker of risk for sporadic large bowel neoplasia.
Rozen
P
P
Department of Gastroenterology, Tel Aviv Medical Center, Tel Aviv University, Israel.
Fireman
Z
Z
Fine
N
N
Chetrit
A
A
Zajicek
G
G
D000230:Adenocarcinoma / Q000473:pathology*; D000236:Adenoma / Q000473:pathology*; D000367:Age Factors; D000368:Aged; D002455:Cell Division / Q000502:physiology; D015179:Colorectal Neoplasms / Q000453:epidemiology / Q000473:pathology* / Q000517:prevention & control; D004847:Epithelial Cells; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening; D008875:Middle Aged; D012007:Rectum / Q000166:cytology / Q000473:pathology*; D012189:Retrospective Studies; D012737:Sex Factors